LAZVUE Trademark

Serial Number: 99593960

LAZVUE is a trademark filed by Beacon Therapeutics Limited on January 14, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Beacon Therapeutics Limited (3 trademarks)

Rolling Stock Yard, 2nd Floor
London N79AS

Entity Type: 24

Legal Representation

Attorney of Record

John Mueller

577 trademarks filed View all →

Correspondence Address

John Mueller Baker & Hostetler LLP

312 Walnut Street, Suite 3200

Cincinnati, OH 45202-4074

United States

Trademark Details

Filing Date

January 14, 2026

Registration Date

Not Registered

Published for Opposition

July 7, 2026

Goods & Services

Pharmaceutical preparations and substances for the treatment of eye diseases and conditions; preparations for gene therapy and cell therapy for the treatment of eye diseases and conditions; Pharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological pharmaceutical preparations for the treatment of ocular disorders; pharmaceutical preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders.

Medical apparatus and instruments for treating eye diseases and conditions; medical apparatus and instruments used in the treatment of ocular disorders; apparatus and instruments for introducing pharmaceutical preparations into the human body; medical apparatus and instruments for the injection of pharmaceutical preparations; medical apparatus and instruments introducing pharmaceutical preparations into the human body for use in gene therapy and cell therapy.

Medical treatment services in the field of eye diseases and conditions; Provision of medical information and services; providing medical information to patients and healthcare professionals concerning pharmaceutical products, preparations for gene therapy and cell therapy, medical diseases and disorders and related treatments; Medical treatment services in the field of ocular disorders; Provision of medical information and services in the field of ocular disorders.